Q&A: What the Executive Order on Regulations Could Mean for EPA, FDA

A conversation with public health expert Lynn Goldman, a former assistant administrator at the US Environmental Protection Agency

Written byJoshua A. Krisch
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The headquarters of the United States Environmental Protection Agency in Washington, D.CWIKIMEDIA, COOLCAESERPresident Donald Trump signed an executive order on January 30, requiring that federal agencies repeal two regulations for every new one they propose. In a statement, Rick Pollack, chief executive officer of the American Hospital Association, praised the order as a step toward removing “red tape” that can drive up health care costs. Meanwhile, Joan Claybrook, former head of the National Highway Traffic Safety Administration, had a decidedly less optimistic reaction. “People are going to die if you start eliminating safety standards,” she told the Los Angeles Times.

Lynn Goldman, dean of the George Washington University Milken Institute School of Public Health and a former assistant administrator for the Environmental Protection Agency (EPA)’s Office of Chemical Safety and Pollution Prevention, spoke with The Scientist about the executive order, and the impact it may have on federal agencies including the EPA and the Food and Drug Administration (FDA).

The Scientist: What do you think was President Trump’s goal in issuing this order?

Lynn Goldman: I think his intent is to follow through on a commitment made in the campaign to reduce regulation, and I believe there was then a verbal commitment that, for every regulation issued, two would be eliminated. And, overall, there are many supporters of the president who sense the importance of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a woman with her hands across her stomach. She has a look of discomfort on her face. There is a blown up image of her stomach next to her and it has colorful butterflies and gut bacteria all swarming within the gut.
November 2025, Issue 1

Why Do We Feel Butterflies in the Stomach?

These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".

View this Issue
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.

Long-Read RNA Sequencing Reveals a Regulatory Role for Splicing in Immunotherapy Responses

Pacific Biosciences logo
Research Roundtable: The Evolving World of Spatial Biology

Research Roundtable: The Evolving World of Spatial Biology

Conceptual cartoon image of gene editing technology

Exploring the State of the Art in Gene Editing Techniques

Bio-Rad
Conceptual image of a doctor holding a brain puzzle, representing Alzheimer's disease diagnosis.

Simplifying Early Alzheimer’s Disease Diagnosis with Blood Testing

fujirebio logo

Products

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS

The Scientist Placeholder Image

Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics

OGT logo

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel